Market Share of Global Cancer Supportive Care Drugs Industry
The majority of the cancer supportive care drugs are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. The market is partially fragmented making it very competitive. Moreover, Asia-pacific is witnessing an emergence of some small players, which has helped the market growth in these regions and has also increased competition for market share. Some of the companies which are currently dominating the market are Amgen Inc., Novartis AG, Merck & Co. Inc, F. Hoffmann-La Roche AG, and Johnson & Johnson among others.
Cancer Supportive Care Drugs Market Leaders
Amgen Inc.
Novartis AG
Merck & Co. Inc
Johnson & Johnson
F. Hoffmann-La Roche AG
*Disclaimer: Major Players sorted in no particular order
